BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16895651)

  • 21. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells.
    Hu H; Cohen JI
    Virology; 2005 Jul; 337(2):304-11. PubMed ID: 15913699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella-Zoster Virus Expresses Multiple Small Noncoding RNAs.
    Markus A; Golani L; Ojha NK; Borodiansky-Shteinberg T; Kinchington PR; Goldstein RS
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency.
    Sato H; Pesnicak L; Cohen JI
    J Med Virol; 2003; 70 Suppl 1():S79-81. PubMed ID: 12627493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.
    Chow VT; Tipples GA; Grose C
    Infect Genet Evol; 2013 Aug; 18():351-6. PubMed ID: 23183312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian varicella: a model for human varicella-zoster virus infections.
    Gray WL
    Rev Med Virol; 2004; 14(6):363-81. PubMed ID: 15386593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome.
    Faga B; Maury W; Bruckner DA; Grose C
    Virology; 2001 Feb; 280(1):1-6. PubMed ID: 11162813
    [No Abstract]   [Full Text] [Related]  

  • 29. Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency.
    Hoover SE; Cohrs RJ; Rangel ZG; Gilden DH; Munson P; Cohen JI
    J Virol; 2006 Apr; 80(7):3459-68. PubMed ID: 16537613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of varicella zoster virus.
    Bostíková V; Bostík P; Chlíbek R; Schmid DS; Salavec M; Smetana J; Splino M
    Epidemiol Mikrobiol Imunol; 2010 Feb; 59(1):21-4. PubMed ID: 21105566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia.
    Schünemann S; Mainka C; Wolff MH
    Acta Virol; 1999 Dec; 43(6):337-40. PubMed ID: 10825921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome differences among varicella-zoster viruses isolated in Thailand.
    Thawaranantha D; Balachandra K; Jongtrakulsiri S; Yamkunthong W; Chimabutra K; Bhumiswasdi J
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):677-83. PubMed ID: 9139375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5.
    Sauerbrei A; Wiesener N; Zell R; Wutzler P
    Arch Virol; 2011 Mar; 156(3):505-9. PubMed ID: 21116830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
    Breuer J; Schmid DS
    J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus.
    Chen JJ; Gershon AA; Li ZS; Lungu O; Gershon MD
    J Med Virol; 2003; 70 Suppl 1():S71-8. PubMed ID: 12627492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring prevalence of varicella-zoster virus clades in Germany.
    Sauerbrei A; Stefanski J; Philipps A; Krumbholz A; Zell R; Wutzler P
    Med Microbiol Immunol; 2011 May; 200(2):99-107. PubMed ID: 21072536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-zoster virus latency in human ganglia.
    Kennedy PG
    Rev Med Virol; 2002; 12(5):327-34. PubMed ID: 12211045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic analysis of clinical varicella-zoster virus isolates collected in China].
    Gan L; Wang ML; Zhao J; Chen JX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):189-93. PubMed ID: 21215082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.
    Peters GA; Tyler SD; Grose C; Severini A; Gray MJ; Upton C; Tipples GA
    J Virol; 2006 Oct; 80(19):9850-60. PubMed ID: 16973589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.